small caps

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for...

Barring some sort of huge selloff today, we’re on track for the seventh-straight winning month.  That would be the longest positive streak for the S&P 500 Index (SPX) since 2017, but investors need to avoid becoming complacent. Markets go down as well as up, and September...

Welcome to halftime. Sorry, there’s no concert.  There’s also not a lot of action in the markets after a mixed performance overseas earlier Wednesday. We’re in wait-and-see mode ahead of Friday’s monthly payrolls report, so it wouldn’t be surprising if this is...

The Last Week In A Nutshell What Happened: Last week ended positive, with broad gains in all S&P 500 sectors. Remember This: “Some data suggests consumer health has started to improve,” said Lindsey Bell, chief investment strategist at Ally Financial Inc (NYSE: ALLY)-owned Ally...

By Avi Gilburt, ElliottWaveTrader.net Right before I had to undergo a surgery at the end of the first week of February, I began to pen an article regarding the potential bearish set up in IWM as a follow up to the bearish analysis I posted about EEM earlier that week entitled...

If you read a lot of financial news, you’ll see many daily market stories that focus on the performance of three U.S. stock market indices: the S&P 500 Index (INDEXSP: .INX), the Dow Jones Industrial Average (INDEXDJX: .DJI), and the NASDAQ Composite Index (...

It’s been a month of ups and downs for equities. After the Aug. 2 close of 2,934.50, S&P 500 futures plunged by as much as 5.4% during the next two days. Although the contract eventually found support near 2,820 and recovered to 2,930, prices have since seesawed between these levels two...

OTC Markets, the market for stocks that don’t trade on U.S. exchanges, announced Tuesday a new compliance tool that they hope will make it easier to identify and analyze risk for small cap listed stocks. The Small-Cap Listed Compliance Product analyzes listed stocks with market caps below $...

For most of 2017, volatility has remained tame, but heading into the final weeks of trading, small-cap stocks may be in for a volatile ride. The Expert Matt Maley, an equity strategist with Miller Tabak. The Strategy As the White House appears ready to debate the tax bill, the small-cap iShares...

Sure, U.S. small-cap stocks and the related exchange-traded funds have recently been resurgent. Give the widely followed Russell 2000 Index some credit for jumping more than 4 percent over the past month to bring its year-to-date gain to almost 11 percent. An 11 percent year-to-date gain is nice,...

Small-cap stocks as measured by the iShares Russell 2000 Index (ETF) (NYSE: IWM) hit an all-time high this week, but investors should look to take some of their profit off the table, at least according to Rich Ross of Evercore ISI. Taking a step back, the Russell 2000 has been showing some signs of...

Shares of Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) continued trading higher on Tuesday after Monday's strong gains. Cyclacel issued a press release over the weekend which detailed a presentation from independent investigators. The investigation highlighted the therapeutic potential of...

The typical “flight to safety” investments have been strong performers since the Brexit vote caught the world off guard last week. The iShares Barclays 20+ Yr Treas.Bond (ETF) (NASDAQ: TLT) is up 5.5 percent, and the SPDR Gold Trust (ETF) (NYSE: GLD) is up 4.4 percent, while the SPDR S...

It has been a ho-hum year for small-cap stocks as highlighted by a gain of 0.75 percent for the benchmark Russell 2000, and things are mixed for micro-cap exchange-traded funds — as just one of the three ETFs dedicated to smaller small-caps is up on the year. An interesting election year...